Sign In
Buy GSK
$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
GSK, AstraZeneca: Will the two UK drugs giants ride the US$74bn pharma wave or will they be left beached?
07:54am, Friday, 06'th Jan 2023
The global pharma sector is expected to see clinical trial readouts that could potentially de-risk approximately US$74bn of peak sales in 2023, according to a research report from Credit Suisse, This
GSK Signs Deal to Develop Antibodies for Treating Cancer
02:17pm, Thursday, 05'th Jan 2023
GSK (GSK) partners with WuXi Biologics to develop bi- & multi-specific T-cell engaging antibodies. GSK will have an exclusive license to develop and commercialize these candidates.
GSK's New Drugs and Pipeline Hold the Key to Growth in 2023
09:01am, Tuesday, 03'rd Jan 2023
GSK's specialty products like Dovato, Nucala, Trelegy Ellipta and Shingrix are likely to drive sales, making up for the lower sales of established drugs due to generic erosion.
3 Beaten-Down Drug Stocks Poised for a Turnaround in 2023
11:36am, Wednesday, 28'th Dec 2022
Here we present three drug and biotech stocks, VIR, GLPG and PCRX, which took a beating in 2022 but have upside potential for 2023, despite an uncertain macro environment.
3 Big Drug, Biotech Stocks to Boost Your Portfolio in 2023
10:51am, Wednesday, 28'th Dec 2022
Here we discuss three big drug and biotech companies, Sanofi (SNY), GSK (GSK) and BioNTech (BNTX), which may prove to be good bets for your portfolio next year.
4 Top Biotech Stocks Worth Adding to Your Portfolio in 2023
12:47pm, Tuesday, 27'th Dec 2022
New drug approvals and focus on coronavirus treatments should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position GILD, GSK, IMCR
GSK or TECH: Which Is the Better Value Stock Right Now?
12:47pm, Monday, 26'th Dec 2022
GSK vs. TECH: Which Stock Is the Better Value Option?
7 Drug Stocks That Will Soar in 2023
06:00am, Thursday, 22'nd Dec 2022
Choosing the best drug stocks to buy can be dicey because drug stocks have disadvantages and advantages. On the negative side, you often have to wait many years for promising drugs to prove themselves
Options Trader Betting On GSK Stock Rising Heading Into 2023 - GSK (NYSE:GSK)
10:49am, Tuesday, 13'th Dec 2022
Options traders are making big bets on the upside for healthcare, particularly in shares of GSK plc GSK.
GSK to move global headquarters back to central London
10:12am, Tuesday, 13'th Dec 2022
GSK PLC (LSE:GSK, NYSE:GSK) is moving its global headquarters back to central London in 2024 in a major boost for the West End economy relocating from its current base in Brentford where it has be
Wave, GSK enter strategic collaboration
08:04am, Tuesday, 13'th Dec 2022
Shares of Wave Life Sciences Ltd. WVE, -7.20% jumped about 17% in premarket trading on Tuesday after the company announced a four-year strategic collaboration with GlaxoSmithKline GSK, -0.72% to devel
GSK & Others Get Relief as US Court Dismisses Zantac Litigation
12:03pm, Thursday, 08'th Dec 2022
A U.S. district court dismisses thousands of lawsuits involving Zantac. Relief for GSK (GSK), Sanofi (SNY) and Pfizer (PFE).
GSK gets chunky Citi target upgrade after Zantac ruling
08:46am, Thursday, 08'th Dec 2022
GSK has had a target price increase to £17 from £15.50 from Citibank following the latest judicial ruling in the Zantac case in the US, but the pharma remains only a 'hold' even so. Following the ru
GSK remains on sell list at UBS despite Zantac ruling
07:40am, Wednesday, 07'th Dec 2022
GSK PLC (LSE:GSK, NYSE:GSK) remained on the sell list at UBS despite the favourable Zantac ruling in the US today which it said “is clearly a positive development for the defendants.” But it point
GSK soars on Zantac ruling but litigation process likely to be lengthy
06:52am, Wednesday, 07'th Dec 2022
Pharmaceutical giants GSK PLC (LSE:GSK, NYSE:GSK) (GSK.L), Pfizer Inc (NYSE:PFE) (PFE.N), Sanofi SA (SASY.PA) and Boehringer Ingelheim received a boost today as a US court ruled that claims the he
